BFM
DGX icon

Boothbay Fund Management’s Quest Diagnostics DGX Stock Holding History

Boothbay Fund Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$334K Sell
1,705
-2,336
-58% -$454K ﹤0.01% 1564
2025
Q4 		$701K Buy
+4,041
New +$736K 0.01% 968
2025
Q1 		– Sell
-2,940
Closed -$444K – 1489
2024
Q4 		$444K Buy
+2,940
New +$457K 0.01% 922
2024
Q3 		– Sell
-2,157
Closed -$295K – 1679
2024
Q2 		$295K Buy
+2,157
New +$295K 0.01% 1163
2024
Q1 		– Sell
-2,337
Closed -$322K – 1648
2023
Q4 		$322K Buy
2,337
+569
+32% +$74.8K 0.01% 1160
2023
Q3 		$215K Buy
+1,768
New +$236K 0.01% 1403
2021
Q2 		– Sell
-2,154
Closed -$276K – 1903
2021
Q1 		$276K Buy
2,154
+149
+7% +$18.4K 0.01% 1231
2020
Q4 		$239K Buy
+2,005
New +$244K 0.01% 1030
2020
Q3 		– Sell
-3,040
Closed -$346K – 1080
2020
Q2 		$346K Sell
3,040
-60
-2% -$6.36K 0.02% 666
2020
Q1 		$249K Buy
+3,100
New +$321K 0.02% 615
2018
Q3 		– Sell
-2,538
Closed -$279K – 819
2018
Q2 		$279K Sell
2,538
-518
-17% -$54K 0.02% 501
2018
Q1 		$307K Sell
3,056
-308
-9% -$31.5K 0.04% 467
2017
Q4 		$331K Buy
+3,364
New +$319K 0.05% 397
2017
Q3 		– Sell
-3,394
Closed -$377K – 631
2017
Q2 		$377K Buy
3,394
+1,323
+64% +$140K 0.08% 340
2017
Q1 		$203K Sell
2,071
-2,348
-53% -$224K 0.04% 599
2016
Q4 		$277 Buy
+4,419
New +$381K 0.06% 429

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Boothbay Fund Management's DGX Position: Q1 2026 in Review

Boothbay Fund Management reduced its Quest Diagnostics (DGX) stake by 58% in Q1 2026, selling an estimated $454K and leaving 1,705 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #1564.

Boothbay Fund Management first reported a position in DGX in Q4 2016 and has held it in 16 quarters since. The position peaked at $701K in Q4 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Boothbay Fund Management held 1,705 shares of Quest Diagnostics worth $334K as of Q1 2026.
  • Boothbay Fund Management sold 2,336 Quest Diagnostics shares in Q1 2026, an estimated $454K.
  • Quest Diagnostics made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1564 holding.
  • Boothbay Fund Management first reported a position in Quest Diagnostics in Q4 2016 and has held it in 16 quarters since.
  • Boothbay Fund Management's Quest Diagnostics position peaked at $701K in Q4 2025.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.